Proceedings.

Boaz Pharmaceuticals Inc.

Follow
Closed
Proceeding
Bankruptcysection 49 of the Bankruptcy and Insolvency Act
File
25-2913225
Filings held3
Last activity5 Sep 2024
On the record1,312 days
OverviewSummary updated

Boaz Pharmaceuticals Inc. entered bankruptcy on September 5, 2024 under the Bankruptcy and Insolvency Act, with the proceeding seated in the Court of King's Bench of Alberta and carried under court file number 25-2913225. Administration of the estate has been conducted in Alberta since that commencement date. The file now stands closed, bringing the Alberta bankruptcy of the pharmaceutical company to its conclusion.

Proceedings AIAsk this case — answers cite the filings
Ask in plain language. The answer comes only from this case’s filings, each one cited.
Enter to send · Shift+Enter for a new line
Case updates3 dated entries
Parties

Debtor

Boaz Pharmaceuticals Inc.

Trustee in bankruptcy

Deloitte

RecoveriesAs stated in the filings

Closed · the record states no distribution outcome.

Documents3 filings
DateDocumentFile
Order Discharging Trustee
  • Commencement date 5 September 2024
  • Court COURT OF KING'S BENCH OF ALBERTA
  • Court file no 25-2913225
PDF
Notice of Bankruptcy and First Meeting of CreditorsPDF
Certificate of Appointment
  • Appointee Deloitte Restructuring Inc
  • Appointee role Licensed Insolvency Trustee
  • Commencement date 17 February 2023
  • Court file no 25-2913225
  • + 1 more extracted fact
PDF

Filing titles, dates, and extracted key facts are public.

CiteProceedings., “Boaz Pharmaceuticals Inc.” (Bankruptcy), Court of King's Bench of Alberta. Retrieved 20 September 2026, https://proceedings.ca/case/boaz-pharmaceuticals-inc

Sources last checked · summary updated 19 August 2026 · Report a correction · Printed from proceedings.ca/case/boaz-pharmaceuticals-inc

Facts and summaries are extracted automatically from the court filings linked on each page; the filings remain the authoritative record. Suggested corrections are reviewed against the source filings.